26
|
Mignard C, Deschamps-Huvier A, Duval-Modeste AB, Dutriaux C, Khammari A, Avril MF, Mortier L, Lesimple T, Gaudy-Marqueste C, Lesage C, Machet L, Aubin F, Meyer N, Beneton Benhard N, Jeudy G, Montaudié H, Arnault JP, Leccia MT, Joly P, Oncology Research Group Of The French Society Of Dermatology S. Efficacy of immunotherapy in patients with metastatic mucosal or uveal melanoma. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy289.026] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
27
|
Guillot B, Charles J, Jeudy G, Cupissol D, Dupuy A, Dutriaux C, Gangloff D, Magne N, Mirabel X, M'Sadek A, Pracht M, Sichel C, Do Outeiro G. Republication de : Traitements des patients atteints de mélanome de stade III inopérable ou de stade IV. Société française de dermatologie. Bull Cancer 2018; 105:780-789. [DOI: 10.1016/j.bulcan.2018.06.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
28
|
Crépin JC, Martinet J, Jeudy G, Aubriot Lorton MH, Chrétien ML, Huther M, Vabres P, Bonniaud B. Épidermolyse bulleuse acquise à IgM Kappa révélatrice d’une maladie de Waldenström. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.085] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
29
|
Herms F, Haudebourg L, Bagot M, Dalac S, Dutriaux C, Grob JJ, Guillot B, Jeudy G, Lambert J, Lebbé C, Mateus C, Meyer N, Monestier S, Mortier L, Poulalhon N, Prey S, Robert C, Vabres P, Mouri M, Basset-Seguin N. Carcinomes basocellulaires localement avancés traités par vismodégib : devenir des rémissions complètes après arrêt du traitement. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.146] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
30
|
Lesage C, Longvert C, Prey S, Maanaoui S, Dréno B, Machet L, Zehou O, Kramkimel N, Jeudy G, Skowron F, Aubin F, Visseaux L, Mansard S, Guillot B. Incidence et impact du traitement par anti-TNFα des colites sévères sous immunothérapie du mélanome : étude MECOLIT. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.533] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
31
|
Plaquevent M, Tetart F, Fardet L, Oro S, Bernard P, Roussel A, Avenel-Audran M, Chaby G, D’incan M, Souteyrand P, Duvert-Lehembre S, Picard-Dahan C, Jeudy G, Labeille B, Morice C, Richard MA, Bourgault Villada I, Litrowski N, Bara C, Mahe E, Prost C, Alexandre M, Quereux G, Soria A, Thomas-Beaulieu D, Pauwels C, Joly P. Pemphigoïdes bulleuses associées aux gliptines : mythe ou réalité ? Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.083] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
32
|
Bertrand A, Ofaiche J, Bernard P, Lipsker D, Saillard C, Granel-Brocard F, Jachiet M, Ledard AP, Aubin F, Avenel-Audran M, Chaby G, Jeudy G, Meunier L, Richard MA, Joly P, Guillot B, Dereure O. Place du rituximab dans les pemphigoïdes bulleuse et gestationnelle : étude rétrospective nationale multicentrique de 48 observations. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.088] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
33
|
Palladini A, Huther M, Bonniaud B, Barra CC, Pottecher P, Casasnovas R, Legouge C, Dalac-Rat S, Vabres P, Jeudy G. Lymphome anaplasique CD30+ musculaire primitif à révélation cutanée. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.453] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
34
|
Moris V, Chapuis A, Guillier D, Jeudy G, Huther M, Auffret N, Piroth L, Blot M. Necrotizing fasciitis caused by genogroup × Neisseria meningitidis. QJM 2017; 110:589-590. [PMID: 28911029 DOI: 10.1093/qjmed/hcx109] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/23/2017] [Indexed: 11/12/2022] Open
|
35
|
Auvens C, Bouldoires B, Jeudy G, Bonniaud B, Dalac S, Berthier S, Leguy-Seguin V, Pasteur J, Audia S, Nicolas B, Guilhem A, Bonnotte B. Conduite à tenir devant un cancer indifférencié mettant en jeu le pronostic vital. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.03.168] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
36
|
Bertrand AS, Ofaiche J, Bernard P, Lipsker D, Saillard C, Granel-Brocart F, Jachiet M, Pham-Ledard A, Aubin F, Avenel-Audran M, Chaby G, Jeudy G, Meunier L, Richard MA, Joly P, Guillot B, Dereure O. Place du rituximab dans les pemphigoïdes bulleuse et gestationnelle : étude rétrospective nationale multicentrique de 48 observations. Ann Dermatol Venereol 2016. [DOI: 10.1016/j.annder.2016.09.211] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
37
|
Pasteur J, Boulitrop C, Collet E, Bou Assi E, Aussedat M, Jeudy G, Vabres P. Nécroses cutanées sévères aux points d’injection d’apomorphine. Ann Dermatol Venereol 2016. [DOI: 10.1016/j.annder.2016.09.661] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
38
|
Bonigen J, Raynaud-Donzel C, Hureaux J, Kramkimel N, Blom A, Jeudy G, Breton AL, Hubiche T, Bedane C, Legoupil D, Pham-Ledard A, Charles J, Pérol M, Gérard E, Combemale P, Bonnet D, Sigal ML, Mahé E. Anti-PD1-induced psoriasis: a study of 21 patients. J Eur Acad Dermatol Venereol 2016; 31:e254-e257. [PMID: 27739129 DOI: 10.1111/jdv.14011] [Citation(s) in RCA: 131] [Impact Index Per Article: 16.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
39
|
Gandon C, Bonniaud B, Collet E, Dalac S, Jeudy G, Vabres P. A Typical Vascular and Pigmentary Dermoscopic Pattern of Capillary Malformations in Capillary Malformation-Arteriovenous Malformation Syndrome: Report of Four Cases. Pediatr Dermatol 2016; 33:e337-41. [PMID: 27480194 DOI: 10.1111/pde.12937] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
We report dermoscopic characteristics of cutaneous capillary malformations in four patients with capillary malformation-arteriovenous malformation (CM-AVM) syndrome. We observed a mixed vascular and pigmentary pattern with branched linear vessels and an underlying homogeneous brown background. Disappearance of the vascular pattern on pressure revealed an underlying faint pigmentary reticular pattern. Our results suggest that this typical biphasic pattern on dermoscopy may be useful for the diagnosis of CM-AVM syndrome.
Collapse
|
40
|
Faivre C, Villani AP, Aubin F, Lipsker D, Bottaro M, Cohen JD, Durupt F, Jeudy G, Sbidian E, Toussirot E, Badot V, Barbarot S, Debarbieux S, Delaporte E, Goegebeur G, Morel J, Nassif A, Duru G, Jullien D. Hidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases. J Am Acad Dermatol 2016; 74:1153-9. [PMID: 26965410 DOI: 10.1016/j.jaad.2016.01.018] [Citation(s) in RCA: 45] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2015] [Revised: 01/06/2016] [Accepted: 01/12/2016] [Indexed: 10/22/2022]
Abstract
BACKGROUND Paradoxical hidradenitis suppurativa (HS) induced by biologic agents (BA) is scarcely reported. OBJECTIVE We sought to describe the clinical characteristics and outcome of patients developing paradoxical HS under BA. METHODS This was a multicenter nationwide retrospective study asking physicians to report all cases of HS, confirmed by a dermatologist, occurring during treatment of an inflammatory disease by a BA. RESULTS We included 25 patients (15 inflammatory rheumatism, 9 Crohn's disease, 1 psoriasis) treated by 5 BA (adalimumab = 12, infliximab = 6, etanercept = 4, rituximab = 2, tocilizumab = 1). Median duration of BA exposure before HS onset was 12 (range 1-120) months. Patients were mostly Hurley stage I (n = 13) or II (n = 11). Simultaneously to HS or within 1 year, 11 patients developed additional inflammatory diseases, including paradoxical reactions (psoriasis = 9, Crohn's disease = 3, alopecia areata = 1, erythema elevatum diutinum = 1). Complete improvement of HS was more frequently obtained after BA discontinuation or switch (n = 6/10, 60%) rather than maintenance (n = 1/14, 7%). Reintroducing the same BA resulted in HS relapse in 3 of 3 patients. LIMITATIONS Retrospective nature and lack of complete follow-up for some patients are limitations. CONCLUSION HS is a rare paradoxical adverse effect of BA, but fortuitous association cannot be excluded in some cases. We observed a trend toward better outcome when the BA was discontinued or switched.
Collapse
|
41
|
Chami I, Dalle S, Leccia M, Lacour J, Mortier L, Jeudy G, Stoebner PE, Dréno B, Porcher R, Kowal A, Lebbé C. Métastases cérébrales de mélanome traitées par immunothérapies anti-PD1 : efficacité et tolérance. Ann Dermatol Venereol 2015. [DOI: 10.1016/j.annder.2015.10.150] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
42
|
Gandon C, Bonniaud B, Collet E, Dalac S, Jeudy G, Vabres P. Taches café au lait associées aux angiomes plans du syndrome CM-AVM : aspect dermoscopique. Ann Dermatol Venereol 2015. [DOI: 10.1016/j.annder.2015.10.361] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
43
|
Jachiet M, Flageul B, Deroux A, Le Quellec A, Maurier F, Cordoliani F, Godmer P, Abasq C, Astudillo L, Belenotti P, Bessis D, Bigot A, Doutre MS, Ebbo M, Guichard I, Hachulla E, Héron E, Jeudy G, Jourde-Chiche N, Jullien D, Lavigne C, Machet L, Macher MA, Martel C, Melboucy-Belkhir S, Morice C, Petit A, Simorre B, Zenone T, Bouillet L, Bagot M, Frémeaux-Bacchi V, Guillevin L, Mouthon L, Dupin N, Aractingi S, Terrier B. The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a French nationwide study of fifty-seven patients. Arthritis Rheumatol 2015; 67:527-34. [PMID: 25385679 DOI: 10.1002/art.38956] [Citation(s) in RCA: 99] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2014] [Accepted: 11/06/2014] [Indexed: 11/10/2022]
Abstract
OBJECTIVE Hypocomplementemic urticarial vasculitis (HUV) is an uncommon vasculitis of unknown etiology that is rarely described in the literature. We undertook this study to analyze the clinical spectrum and the therapeutic management of patients with HUV. METHODS We conducted a French nationwide retrospective study that included 57 patients with chronic urticaria, histologic leukocytoclastic vasculitis, and hypocomplementemia. We assessed clinical and laboratory data and evaluated the patients' cutaneous and immunologic responses to therapy. We evaluated treatment efficacy by measuring the time to treatment failure. RESULTS Urticarial lesions were typically more pruritic than painful and were associated with angioedema in 51% of patients, purpura in 35%, and livedo reticularis in 14%. Extracutaneous manifestations included constitutional symptoms (in 56% of patients) as well as musculoskeletal involvement (in 82%), ocular involvement (in 56%), pulmonary involvement (in 19%), gastrointestinal involvement (in 18%), and kidney involvement (in 14%). Patients with HUV typically presented with low C1q levels and normal C1 inhibitor levels, in association with anti-C1q antibodies in 55% of patients. Hydroxychloroquine or colchicine seemed to be as effective as corticosteroids as first-line therapy. In patients with relapsing and/or refractory disease, rates of cutaneous and immunologic response to therapy seemed to be higher with conventional immunosuppressive agents, in particular, azathioprine, mycophenolate mofetil, or cyclophosphamide, while a rituximab-based regimen tended to have higher efficacy. Finally, a cutaneous response to therapy was strongly associated with an immunologic response to therapy. CONCLUSION HUV represents an uncommon systemic and relapsing vasculitis with various manifestations, mainly, musculoskeletal and ocular involvement associated with anti-C1q antibodies, which were found in approximately half of the patients. The best strategy for treating HUV has yet to be defined.
Collapse
|
44
|
Jeudy G, Dalac-Rat S, Bonniaud B, Hervieu A, Petrella T, Collet E, Vabres P. Successful switch to dabrafenib after vemurafenib-induced toxic epidermal necrolysis. Br J Dermatol 2015; 172:1454-5. [PMID: 25384395 DOI: 10.1111/bjd.13522] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
45
|
Jeudy G, Dalac-Rat S, Bonniaud B, Hervieu A, Petrella T, Collet E, Vabres P. Syndrome de Lyell sous vémurafénib : substitution par dabrafénib sans récidive. Ann Dermatol Venereol 2014. [DOI: 10.1016/j.annder.2014.09.592] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
46
|
Faivre C, Aubin F, Bottaro M, Cohen JD, Durupt F, Lipsker D, Debarbieux S, Jeudy G, Morel J, Toussirot E, Faure M, Jullien D. Apparition d’une maladie de Verneuil sous biothérapie : une série de 14 cas. Ann Dermatol Venereol 2014. [DOI: 10.1016/j.annder.2014.09.451] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
47
|
Bonniaud B, Maudinas R, Jeudy G, Leleu C, Vabres P, Collet E. Guérison d’une urticaire d’effort après traitement d’une oxyurose. Ann Dermatol Venereol 2014. [DOI: 10.1016/j.annder.2014.09.404] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
48
|
Gandon C, Küry S, Jeudy G, Schmitt S, Thierry G, Bézieau S, Vabres P. Acrodermatite entéropathique par isodisomie uniparentale. Ann Dermatol Venereol 2014. [DOI: 10.1016/j.annder.2014.09.270] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
49
|
Bernigaud C, Collet E, Jeudy G, Hervieu A, Bruyère R, Djerad H, Couderc B, Combret S, Allanore L, Aubriot MH, Vabres P. Toxicité cutanée grave au docétaxel (Taxotère®) au cours d’une infection VIH : rôle des interactions médicamenteuses. Ann Dermatol Venereol 2013. [DOI: 10.1016/j.annder.2013.09.369] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
50
|
Jeudy G, Gandon C, Aubriot-Lorton MH, Collet E, Dalac-Rat S, Vabres P. Lupus tuberculeux méconnu traité par photothérapie dynamique : application du principe de la lampe de Finsen. Ann Dermatol Venereol 2013. [DOI: 10.1016/j.annder.2013.09.317] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|